TEVA ANNOUNCES U.S. FOOD AND DRUG ADMINISTRATION (FDA) APPROVAL OF WELTRUZA™ (OLANZAPINE) FOR EXTENDED-RELEASE INJECTABLE SUSPENSION, AS THE FIRST AND ONLY ONCE-MONTHLY SUBCUTANEOUS INJECTABLE OLANZAPINE FOR ADULTS WITH SCHIZOPHRENIA

Reuters · 1d ago

Please log in to view news